Adequate levofloxacin treatment schedules for uterine cervicitis caused by Chlamydia trachomatis

Chemotherapy

Volumn 46, Issue 2, 2000, Pages 150-152

  Mikamo, Hiroshige ^a   Sato, Yasumasa ^a   Hayasaki, Yoh ^a   Hua, Yin Xiang ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Cervicitis; Chlamydia trachomatis; Levofloxacin; Quinolone, new

Indexed keywords

LEVOFLOXACIN;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE RISK; UTERINE CERVICITIS;

EID: 0033964629     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007270     Document Type: Article

References (12)

1. Center for Disease Control: Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR 1993;42: 1-37.
2. Katz BP, Zwickl BW, Caine VA, Jones RB: Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhea. Sex Transm Dis 1992;19:351-354.
3. Elsner P: Treatment of bacterial sexually transmitted diseases. Semin Dermatol 1993;12:342-351.
4. Hooton TM, Batteigner BE, Judson FN, Spruance SL, Stamm WE: Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother 1992;36: 1144-1146.
5. Maeda H, Fujii A. Nakata K, Arakawa S, Kamidono S: In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains. Antimicrob Agents Chemother 1988;32:1080-1081.
6. Kimura M, Kishimoto T, Niki Y, Soejima R: In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents. Antimicrob Agents Chemother 1993;37:801-803.
7. Fujimaki K, Noumi T, Saikawa I, Inoue M, Mitsuhashi S: In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob Agents Chemother 1988; 32:827-833.
8. Domagala JM: Structure-activity and structure-side-effect relationship for the quinolone antibacterials. J Antimicrob Chemother 1994;33:685-706.
9. Page LA: The rickettsias; in Buchanan RE, Gibbons NE (eds): Bergey's Manual of Determinative Bacteriology, ed 8. Williams & Wilkins, Baltimore, 1974, pp 914-918.
10. Kuo C-C, Wang S-P, Grayston JT: Effect of polycations, polyanions and neuroaminidase on the infectivity of trachoma-inclusion conjunctivitis and lymphogranuloma venereum organisms in HeLa cells: Sialic acid residues as possible receptors for trachoma-inclusion conjunctivitis. Infect Immun 1973;8:74-79.
11. Byrne GI, Moulder JW: Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect Immun 1978;19:598-606.
12. Friis RR: Interaction of L cells and Chlamydia psittaci: Entry of the parasite and host responses to its development. J Bacteriol 1972;110:706-721.